C40H49BrN6O9S
Neat
869.84
Faldaprevir; 801283-95-4; BI-201335; 958X4J301A; (1R, 2S)-1-((2S, 4R)-4-(8-bromo-2-(2-isobutyramidothiazol-4-yl)-7-methoxyquinolin-4-yloxy)-1-((S)-2-(cyclopentyloxycarbonylamino)-3, 3-dimethylbutanoyl)pyrrolidine-2-carboxamido)-2-vinylcyclopropanecarboxylic acid; N-((Cyclopentyloxy)carbonyl)-3-methylvalyl-4-((8-bromo-7-methoxy-2-(2-((2-methylpropanoyl)amino)-1, 3-thiazol-4-yl)quinolin-4-yl)oxy)-N-(1-carboxy-2-ethenylcyclopropyl)prolinamide; DTXSID20230084; faldaprevirum; RefChem:139904; DTXCID20152575; J05AP04; CHEMBL1241348; (1R, 2S)-1-((2S, 4R)-4-((8-bromo-2-(2-isobutyramidothiazol-4-yl)-7-methoxyquinolin-4-yl)oxy)-1-((S)-2-(((cyclopentyloxy)carbonyl)amino)-3, 3-dimethylbutanoyl)pyrrolidine-2-carboxamido)-2-vinylcyclopropane-1-carboxylic acid; (1R, 2S)-1-[[(2S, 4R)-4-[8-bromo-7-methoxy-2-[2-(2-methylpropanoylamino)-1, 3-thiazol-4-yl]quinolin-4-yl]oxy-1-[(2S)-2-(cyclopentyloxycarbonylamino)-3, 3-dimethylbutanoyl]pyrrolidine-2-carbonyl]amino]-2-ethenylcyclopropane-1-carboxylic acid; N-[(Cyclopentyloxy)carbonyl]-3-Methyl-L-Valyl-(4r)-4-[(8-Bromo-7-Methoxy-2-{2-[(2-Methylpropanoyl)amino]-1, 3-Thiazol-4-Yl}quinolin-4-Yl)oxy]-N-[(1r and 2s)-1-Carboxy-2-Ethenylcyclopropyl]-L-Prolinamide; Faldaprevir [INN]; Faldaprevir [USAN:INN]; FALDAPREVIR [USAN]; FALDAPREVIR [WHO-DD]; SCHEMBL222429
trans-(1R, 2S)-1-[[(2S, 4R)-4-[8-bromo-7-methoxy-2-[2-(2-methylpropanoylamino)-1, 3-thiazol-4-yl]quinolin-4-yl]oxy-1-[(2S)-2-(cyclopentyloxycarbonylamino)-3 and 3-dimethylbutanoyl]pyrrolidine-2-carbonyl]amino]-2-ethenylcyclopropane-1-carboxylic acid
InChI=1S/C40H49BrN6O9S/c1-8-21-17-40(21,36(51)52)46-34(49)27-15-23(18-47(27)35(50)32(39(4,5)6)44-38(53)56-22-11-9-10-12-22)55-29-16-25(26-19-57-37(43-26)45-33(48)20(2)3)42-31-24(29)13-14-28(54-7)30(31)41/h8,13-14,16,19-23,27,32H,1,9-12,15,17-18H2,2-7H3,(H,44,53)(H,46,49)(H,51,52)(H,43,45,48)/t21-,23-,27+,32-,40-/m1/s1